Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT05822102
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent obtained from subject
* Diagnosis of CF
* Aged 18 years and older
* Use of ETI that has reached steady state dosing levels of ETI, defined as a continuous dosing regimen for a minimum of 14 days.
Exclusion Criteria:
* A person with CF (pwCF) that is either not taking ETI or dose not follow a continuous dosing regimen for a minimum of 14 days.
* Use of prohibited medications as outlined by package insert
* Pregnant or lactating people with CF
* Acute, severe deterioration in health requiring intensive care unit admission
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05822102
Study Brief:
Protocol Section:
NCT05822102